Letters sent to healthcare professionals in January 2017

A summary of letters sent to relevant healthcare professionals in January 2017.

From:
Medicines and Healthcare products Regulatory Agency
Published
20 February 2017
Therapeutic area:
Cancer, Endocrinology, diabetology and metabolism and Obstetrics, gynaecology and fertility

In January 2017, letters were sent regarding:

  • Insuman (human insulin): end of supply shortage ( and )
  • Mirena (levonorgestrel intrauterine delivery system):
  • Ulipristal acetate (ellaOne):
  • ERWINASE: notice of special handling instructions鈥�
  • DepoCyte (cytarabine):

Article citation: Drug Safety Update volume 10 issue 7, February 2017: 3.

Updates to this page

Published 20 February 2017